EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Investigation of common genetic risk factors between thyroid traits and breast cancer

Elise A Lucotte, Yazdan Asgari, Pierre-Emmanuel Sugier, Mojgan Karimi, Cloé Domenighetti, Fabienne Lesueur, Anne Boland-Augé, Evgenia Ostroumova, Florent de Vathaire, Monia Zidane, Pascal Guénel, Jean-François Deleuze und 4 weitere

Human Molecular Genetics · 12.12.2023 · 33 (1) · 38-47

DOI: 10.1093/hmg/ddad159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 22.09.2023. Verfasst von Elise A Lucotte und 15 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France. Hauptthemen laut MEDLINE: Thyroid Gland, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Research UK, NCI NIH HHS, World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) risk is suspected to be linked to thyroid disorders, however observational studies exploring the association between BC and thyroid disorders gave conflicting results. We proposed an alternative approach by investigating the shared genetic risk factors between BC and several thyroid traits. We report a positive genetic correlation between BC and thyroxine (FT4) levels (corr = 0.13, p-value = 2.0 × 10−4) and a negative genetic correlation between BC and thyroid-stimulating hormone (TSH) levels (corr = −0.09, p-value = 0.03). These associations are more striking when restricting the analysis to estrogen receptor-positive BC. Moreover, the polygenic risk scores (PRS) for FT4 and hyperthyroidism are positively associated to BC risk (OR = 1.07, 95%CI: 1.00–1.13, p-value = 2.8 × 10−2 and OR = 1.04, 95%CI: 1.00–1.08, p-value = 3.8 × 10−2, respectively), while the PRS for TSH is inversely associated to BC risk (OR = 0.93, 95%CI: 0.89–0.97, p-value = 2.0 × 10−3). Using the PLACO method, we detected 49 loci associated to both BC and thyroid traits (p-value < 5 × 10−8), in the vicinity of 130 genes. An additional colocalization and gene-set enrichment analyses showed a convincing causal role for a known pleiotropic locus at 2q35 and revealed an additional one at 8q22.1 associated to both BC and thyroid cancer. We also found two new pleiotropic loci at 14q32.33 and 17q21.31 that were associated to both TSH levels and BC risk. Enrichment analyses and evidence of regulatory signals also highlighted brain tissues and immune system as candidates for obtaining associations between BC and TSH levels. Overall, our study sheds light on the complex interplay between BC and thyroid traits and provides evidence of shared genetic risk between those conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid GlandBreast NeoplasmsHumansFemaleThyrotropinThyroxineRisk FactorsGenetic Risk Score

Stichwörter der Autor:innen

breast cancercross phenotype associationpleiotropythyroid cancerthyroid traits

Substanzen

ThyrotropinThyroxine

Autor:innen und Institutionen

  • Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team "Exposome and Heredity", 94807 Villejuif, France.
  • Laboratoire de Mathématiques et de leurs Applications de Pau, Université de Pau et des Pays de l'Adour, UMR CNRS 5142, E2S-UPPA, 64013 Pau, France.
  • Inserm, U900, Institut Curie, PSL University, Mines ParisTech, 75006 Paris, France.
  • National Centre of Human Genomics Research, François Jacob Institute of Biology, Commissariat à l'Energie Atomique, Paris-Saclay University, 91000 Evry, France.
  • International Agency for Research on Cancer, WHO, 69007 Lyon, France.
  • Paris-Saclay University, UVSQ, Gustave Roussy, Inserm, CESP, Team of Epidemiology of radiations, 94807 Villejuif, France.

Förderung

  • Cancer Research UK
  • NCI NIH HHS
  • World Health Organization
  • ARC
  • The European Union
  • The National Institutes of Health
  • Government of Canada

Zitieren

APA

Lucotte, E. A., Asgari, Y., Sugier, P. E., Karimi, M., Domenighetti, C., Lesueur, F., Boland-Augé, A., Ostroumova, E., de Vathaire, F., Zidane, M., Guénel, P., Deleuze, J. F., Boutron-Ruault, M. C., Severi, G., Liquet, B., & Truong, T. (2023). Investigation of common genetic risk factors between thyroid traits and breast cancer. Human Molecular Genetics, 33(1), 38-47. https://doi.org/10.1093/hmg/ddad159

Vancouver

Lucotte EA, Asgari Y, Sugier PE, Karimi M, Domenighetti C, Lesueur F, et al. Investigation of common genetic risk factors between thyroid traits and breast cancer. Human Molecular Genetics. 2023;33(1):38-47. doi:10.1093/hmg/ddad159

BibTeX
@article{Lucotte2023,
  author = {Lucotte, Elise A and Asgari, Yazdan and Sugier, Pierre-Emmanuel and Karimi, Mojgan and Domenighetti, Cloé and Lesueur, Fabienne and Boland-Augé, Anne and Ostroumova, Evgenia and de Vathaire, Florent and Zidane, Monia and Guénel, Pascal and Deleuze, Jean-François and Boutron-Ruault, Marie-Christine and Severi, Gianluca and Liquet, Benoît and Truong, Thérèse},
  title = {Investigation of common genetic risk factors between thyroid traits and breast cancer},
  journal = {Human Molecular Genetics},
  year = {2023},
  volume = {33},
  number = {1},
  pages = {38--47},
  doi = {10.1093/hmg/ddad159}
}
Kostenlos starten →